These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14091607)

  • 1. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 2. [AN EFFECTIVE ANTIFIBRINOLYTIC AGENT: EPSILON-AMINOCAPROIC ACID].
    GROSSI F
    Clin Ter; 1963 Jul; 26():73-8. PubMed ID: 14050038
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID AS AN ANTIFIBRINOLYTIC AGENT IN VARIOUS OBSTETRICAL DISORDERS].
    PALACIO S; CANO A; YEPES E
    Rev Colomb Obstet Ginecol; 1964; 15():413-9. PubMed ID: 14258173
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECTS OF EPSILON AMINOCAPROIC ACID ON COAGULATION AND FIBRINOLYTIC MECHANISMS.
    LEWIS JH; DOYLE AP
    JAMA; 1964 Apr; 188():56-63. PubMed ID: 14107215
    [No Abstract]   [Full Text] [Related]  

  • 6. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E; LANDE M; LEGER L
    Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753
    [No Abstract]   [Full Text] [Related]  

  • 7. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 8. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
    BRODSKY I; ROSS E; REID WO
    Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048
    [No Abstract]   [Full Text] [Related]  

  • 9. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 10. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M
    Hemostase; 1964 Mar; 4():95-101. PubMed ID: 14188681
    [No Abstract]   [Full Text] [Related]  

  • 11. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 12. USE OF EPSILON AMINOCAPROIC ACID.
    GANS H
    Surg Gynecol Obstet; 1965 Mar; 120():576-7. PubMed ID: 14262059
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
    PERLICK E
    Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146
    [No Abstract]   [Full Text] [Related]  

  • 14. HAEMORRHAGE AND FIBRINOLYSIS.
    FLUTE PT
    Proc R Soc Med; 1964 Jul; 57(7):603-6. PubMed ID: 14178952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemostatic action of epsilon-aminocaproic acid. Experimental research].
    FRANDOLI G
    Gazz Int Med Chir; 1963 Jan; 67():61-70. PubMed ID: 13959206
    [No Abstract]   [Full Text] [Related]  

  • 16. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    SWEENEY WM
    Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294
    [No Abstract]   [Full Text] [Related]  

  • 17. [ANTIFIBRINOLYTIC AGENTS].
    ZWEIBAUM A; JOSSO F
    Rev Prat; 1963 Dec; 13():SUPPL 135-8. PubMed ID: 14099272
    [No Abstract]   [Full Text] [Related]  

  • 18. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS].
    OPPELT HG; BECK L
    Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.